Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?
Case Reports in Neurological Medicine · 2016 · 2016 · 1-3
DOI: 10.1155/2016/3431849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Neurological Medicine, 2016. Verfasst von Ioannis E Dagklis und 5 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Miller-Fisher syndrome (MFS) is considered as a variant of the Guillain-Barre syndrome (GBS) and its characteristic clinical features are ophthalmoplegia, ataxia, and areflexia. Typically, it is associated with anti-GQ1b antibodies; however, a significant percentage (>10%) of these patients are seronegative. Here, we report a 67-year-old female patient who presented with the typical clinical features of MFS. Workup revealed antibodies against glutamic acid decarboxylase (GAD) in relatively high titers while GQ1b antibodies were negative. Neurological improvement was observed after intravenous gamma globulin and follow-up examinations showed a continuous clinical amelioration with simultaneous decline of anti-GAD levels which finally returned to normal values. This case indicates that anti-GAD antibodies may be associated with a broader clinical spectrum and future studies in GQ1b-seronegative patients could determine ultimately their clinical and pathogenetic significance in this syndrome.
Autor:innen und Institutionen
- 3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece.
ORCID-Profile: Ioannis E Dagklis, Dimitrios Kazis
Zitieren
APA
Dagklis, I. E., Papagiannopoulos, S., Theodoridou, V., Kazis, D., Argyropoulou, O., & Bostantjopoulou, S. (2016). Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?. Case Reports in Neurological Medicine, 2016, 1-3. https://doi.org/10.1155/2016/3431849
Vancouver
Dagklis IE, Papagiannopoulos S, Theodoridou V, Kazis D, Argyropoulou O, Bostantjopoulou S. Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?. Case Reports in Neurological Medicine. 2016;2016:1-3. doi:10.1155/2016/3431849
BibTeX
@article{Dagklis2016,
author = {Dagklis, Ioannis E and Papagiannopoulos, Sotirios and Theodoridou, Varvara and Kazis, Dimitrios and Argyropoulou, Ourania and Bostantjopoulou, Sevasti},
title = {Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?},
journal = {Case Reports in Neurological Medicine},
year = {2016},
volume = {2016},
pages = {1--3},
doi = {10.1155/2016/3431849}
}
EUVIMED